Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02198157
Other study ID # 45-14-EMC
Secondary ID
Status Completed
Phase N/A
First received July 21, 2014
Last updated February 20, 2016
Start date July 2014
Est. completion date July 2015

Study information

Verified date February 2016
Source HaEmek Medical Center, Israel
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

- Labor is divided into three stages: the first stage is from labor onset until full dilation, second stage is from full dilation until delivery of the baby, and the third stage from the delivery of the baby until the delivery of the placenta

- The mean duration of second stage in nulliparas as defined by the American college of obstetricians and gynecologists (ACOG) is 54 minutes

- Epidural anesthesia is a known cause for prolongation of the second stage of labor. Prolonged second stage in nullipara women with epidural is defined as more than 3 hours, and more than 2 hours in those without epidural.

- Although perinatal outcome is not compromised with a prolonged second stage , there is evidence that maternal morbidities such as perineal trauma, chorioamnionitis ,instrumental delivery and postpartum hemorrhage increase with prolonged second stage

- Another effect of epidural anesthesia during labor is urinary retention and a need for catheterization.

- Full bladder may behave as a tumor previa and interfere to fetal head descent in the birth canal, increasing by that the duration of the second stage.

- This study aims to investigate the effect of intermittent versus continuous catheterization on the duration of the second stage of labor


Recruitment information / eligibility

Status Completed
Enrollment 184
Est. completion date July 2015
Est. primary completion date May 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

- Nulliparous women

- Gestational age 24-42 weeks

- epidural anaesthesia

- Vertex presentation

- Singleton

Exclusion Criteria:

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
urinary catheterization
nullipara women with epidural anaesthesia who pose urination difficulty will be randomize to receive intermittent or continuous urinary catheterization.

Locations

Country Name City State
Israel Dep. OB/GYN, HaEmek Medical Center Afula

Sponsors (1)

Lead Sponsor Collaborator
Raed Salim

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Other post-partum hemorrhage within the first 48 hours after delivery Yes
Primary duration of second stage of labor within the first 48 hours after delivery No
Secondary chorioamnionitis within the first 48 hours after delivery Yes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT01546129 - Effect of Dianatal Obstetric Gel (Cross-linked Polyacrylic Acid) on Outcomes in Vaginal Delivery Phase 3